HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K H Park Selected Research

human pegylated granulocyte colony-stimulating factor

1/2017A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer.
10/2013A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K H Park Research Topics

Disease

7Neoplasms (Cancer)
01/2023 - 01/2000
5Infections
03/2018 - 12/2001
4Inflammation (Inflammations)
06/2017 - 11/2001
4Breast Neoplasms (Breast Cancer)
01/2017 - 06/2013
3Disseminated Intravascular Coagulation
10/2021 - 10/2000
3Hemorrhage
04/2021 - 10/2000
3Anaphylaxis (Anaphylactic Shock)
09/2018 - 04/2016
3Glaucoma
11/2014 - 06/2001
2Carcinoma (Carcinomatosis)
01/2023 - 11/2000
2Disease Progression
01/2023 - 04/2021
2Bites and Stings (Sting)
10/2021 - 12/2001
2Snake Bites (Snake Bite)
10/2021 - 04/2021
2Acute Kidney Injury (Acute Renal Failure)
04/2021 - 01/2000
2Hypotension (Low Blood Pressure)
04/2021 - 04/2010
2Atopic Dermatitis (Atopic Eczema)
09/2018 - 01/2018
2Asthma (Bronchial Asthma)
01/2018 - 01/2012
2Hypersensitivity (Allergy)
01/2018 - 01/2016
2Neutropenia
01/2017 - 10/2013
2Hypertension (High Blood Pressure)
12/2014 - 04/2010
2Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2014 - 01/2013
2Stroke (Strokes)
06/2012 - 04/2010
2Premature Obstetric Labor (Premature Labor)
10/2011 - 01/2011
2Necrosis
10/2008 - 11/2001
2Stress Urinary Incontinence
01/2003 - 01/2002
2Insulinoma
06/2001 - 04/2001
1Respiratory Insufficiency (Respiratory Failure)
04/2021
1Thrombocytopenia (Thrombopenia)
04/2021
1Viremia
10/2018
1Allergic Rhinitis
01/2018
1Alveolar Bone Loss
06/2017
1Experimental Arthritis
06/2017
1Periodontitis
06/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2016
1Hematologic Neoplasms (Hematological Malignancy)
10/2016
1Immediate Hypersensitivity
01/2016
1Heart Failure
12/2015

Drug/Important Bio-Agent (IBA)

4Retinaldehyde (Retinal)IBA
05/2010 - 10/2008
3AllergensIBA
09/2018 - 01/2012
3Interleukin-6 (Interleukin 6)IBA
06/2017 - 01/2011
3Docetaxel (Taxotere)FDA Link
01/2017 - 03/2005
3Hormones (Hormone)IBA
01/2014 - 01/2003
2human ERBB2 proteinIBA
01/2023 - 06/2013
2Biosimilar PharmaceuticalsIBA
01/2023 - 10/2013
2VenomsIBA
10/2021 - 04/2021
2Antivenins (Antivenoms)IBA
10/2021 - 04/2021
2Immunoglobulin E (IgE)IBA
01/2018 - 04/2016
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2017 - 11/2001
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2017 - 10/2013
2human pegylated granulocyte colony-stimulating factorIBA
01/2017 - 10/2013
2Filgrastim (Neupogen)FDA Link
01/2017 - 10/2013
2Messenger RNA (mRNA)IBA
10/2016 - 03/2007
2Glucose (Dextrose)FDA LinkGeneric
12/2014 - 11/2000
2Bevacizumab (Avastin)FDA Link
06/2013 - 02/2010
2EnzymesIBA
12/2012 - 01/2010
2ImmunosorbentsIBA
12/2012 - 01/2010
2C-Reactive ProteinIBA
10/2011 - 01/2011
2SteroidsIBA
04/2010 - 01/2003
2ZincIBA
01/2002 - 06/2001
2AndrogensIBA
01/2000 - 01/2000
2Complementary DNA (cDNA)IBA
01/2000 - 01/2000
1Trastuzumab (Herceptin)FDA Link
01/2023
1Paclitaxel (Taxol)FDA LinkGeneric
01/2023
1fibrin fragment D (D-dimer)IBA
10/2021
1Blood Coagulation Factors (Coagulation Factor)IBA
10/2021
1Fibrinogen (Factor I)FDA Link
10/2021
1Troponin IIBA
04/2021
1VaccinesIBA
10/2018
1Cephalosporins (Cephalosporin Antibiotics)IBA
09/2018
1Cefuroxime (Zinacef)FDA LinkGeneric
09/2018
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
09/2018
1Cefoxitin (Cefoxitin Sodium)FDA LinkGeneric
09/2018
1cefminoxIBA
09/2018
1Cefotaxime (Kendrick)FDA LinkGeneric
09/2018
1Cefmetazole (Cefmetazole Sodium)FDA Link
09/2018
1Cefepime (Maxipime)FDA LinkGeneric
09/2018
1Ceftizoxime (Cefizox)FDA Link
09/2018
1CefotiamFDA Link
09/2018
1antineoplaston A10 (A 10)IBA
01/2018
1Interleukin-8 (Interleukin 8)IBA
06/2017
1Nicotinamide PhosphoribosyltransferaseIBA
06/2017
1iobitridolIBA
01/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017
1Iohexol (Omnipaque)FDA Link
01/2017
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2017
1iopromide (Ultravist)FDA Link
01/2017
1Iopamidol (Isovue)FDA LinkGeneric
01/2017
1Histone Deacetylases (Histone Deacetylase)IBA
10/2016
1Histone Deacetylase InhibitorsIBA
10/2016
1Ranitidine (Zantac)FDA LinkGeneric
04/2016
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2016
1PlatinumIBA
01/2016
1Carvedilol (Coreg)FDA LinkGeneric
12/2015
1Metoprolol (Toprol-XL)FDA LinkGeneric
12/2015
1Bisoprolol (Concor)FDA LinkGeneric
12/2015
1Triglycerides (Triacylglycerol)IBA
12/2014

Therapy/Procedure

6Therapeutics
10/2016 - 01/2000
4Drug Therapy (Chemotherapy)
01/2017 - 05/2004
2Combination Drug Therapy (Combination Chemotherapy)
01/2017 - 03/2005
1Immunotherapy
09/2018
1Intramuscular Injections
03/2018